Craniofacial Neuropathic Pain
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1.Patients aged 18–85 years. 2.Patients clinically diagnosed with craniofacial neuropathic pain (mainly trigeminal neuralgia, postherpetic neuralgia, pterygopalatine neuralgia, glossopharyngeal neuralgia, etc.) with a Numeric Rating Scale (NRS) score >=4. 3.Failure of previous conservative treatments, such as physical therapy, exercise therapy, or analgesic medications. 4.Subjects voluntarily sign the informed consent form and agree to complete the follow-up required by the trial protocol. 5.Receive treatment according to the protocol during the treatment period.
Exclusion criteria
Exclusion criteria: 1.Severe cardiac, cerebral, renal, or hepatic insufficiency; abnormal coagulation function 2.Hemorrhage, local or systemic infection, active pulmonary tuberculosis 3.Patients with stroke or vertigo 4.Patients with mental disorders or intellectual disabilities who cannot cooperate with treatment or follow-up 5.Patients with neuropathic pain for whom radiofrequency treatment is not appropriate 6.Allergy to steroids or contrast agents 7.Presence of contraindications to puncture, such as infection at the puncture site 8.Other conditions that the investigator considers unsuitable for participation in this trial
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Whether blood is aspirated during the puncture procedure.; | — |
Secondary
| Measure | Time frame |
|---|---|
| Time from puncture initiation to completion.;Intraprocedural Vital Sign Changes;Postoperative complications: such as cheek swelling, sensory abnormalities, infection, etc.;Efficacy in treating neuropathic pain: NRS scores at 3 days, 1 month, and 3 months postoperatively.; | — |
Countries
China
Contacts
The Third Xiangya Hospital, Central South University, Changsha, Hunan Province